Flow cytometry analysis of the TME revealed both PD-L1 and MHC-I expression on CD45+ leukocytes, CD45.2−/EpCAM+ tumor cells and CD45.2−/EpCAM−/CD90.1+ CAFs (Fig. 3B-C). This evidence concerns the gene EPCAM and neoplasm.